Yeah could be 3 million shares at 20.00 in june adage buys or maybe baker brothers haha
If it ran to over 13.00 last time with institutions buying at 4.25 and about 20% ownership,this second buy by institutions at 7.50 and about 48% ownership. Still trading at 300mm cap when most are over a billion,16-20 is easy this go around.
The float is very low,easy to move either way,but the 7.50 buys by adage will support the stock.
ADXS went from 0 ownership to 48% ownership in 60 days,adage capital bought 18% at 4.25,added another 5% at 7.50,T Rowe price did the same. ADXS has collaborations with Merck,INCY,Astrazenca,Brown Univ,and (3) Merck employees left to work for ADXS.Has it occurred to you maybe it ran too quick,institutions wanted in on the next big thing.Also I expect to see more institutional buying the next report March31 of over 50% ownership.
I'm working on it but here's one QCOR shorts write lie after lie,stating obamacare will no longer cover. QCOR in 2 weeks dropped 62.00-17.00,1 year later sold for 95.00,many stop losses were taken out,that's how they drove it 17.00.
Really if you held 6mos at 4.00 in 2006-2007 you made 500%,and would be A fool not to take profit,6mos in 2008-2009 at 2.00 2900% profit,once again you'd be fool if you didn't sell something,your bk statement is invalid.
Also look at ADXS AND CTSO, adage capital and t rowe price bought twice in last 60 days on ADXS,CTSO doesn't have much ownership yet,but I believe that will all change on next institutions holdings report.
otherwise you are correct not many ones with this much potential,APTO is a recent ipo,not on many peoples radar either....
APTO has 58mm cap,target price 17.00 by 25th ranked analyst in the world,plus has 27% ownership,which is in Phase III clinical trial for the treatment of acute myeloid leukemia; and Virulizin, a novel immunotherapy agent that has completed three Phase I/II clinical studies in solid tumors and pancreatic cancers, as well as completed a randomized placebo-controlled Phase III .
Most those plays were #$%$,never thought any them had a shot,besides onty,but CEO didn't seem straight up,so I should have known better.
If you use stop orders on biotechs expect lose your a@@,I know people who bought dndn on my advice,waited last minute,bought at 11.00-13.00. Bear raid came,10.80 stop loss he had in was sold at 7.80,next morning stocks 26.00. Hey what do I know,use stop loss at your own peril,stop losses are for blue chips.
He's been here 4+years,I doubt he's a paid promoter,he also bought at .04,so whose losing.....sometimes I think these bashers are working for big pharma...